Position in PRGO
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$8,644,153
-$6,095,884 QoQ
Shares Held
804,856
+40.2% QoQ
Ownership
0.582%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
16 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in PRGO Over Time
Shares Held
Position Value (USD)
Derivatives in PRGO
reported options exposure · as of Jun 30, 2022CallValue
$10,953,900
CallShares
270,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Balyasny Asset Management L.P. holds $180,059,722 across 19 Drug Manufacturers - Specialty & Generic names. PRGO ranks #8 (4.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LNTH |
Lantheus Holdings, Inc.
|
539,382 | $40,912,124 | |
| 2 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
499,792 | $24,064,984 | |
| 3 | BIOA |
BioAge Labs, Inc.
|
1,327,545 | $23,218,762 | |
| 4 | UTHR |
UNITED THERAPEUTICS Corp
|
36,623 | $21,716,706 | |
| 5 | ALKS |
Alkermes plc.
|
586,775 | $20,748,363 | |
| 6 | AMLX |
Amylyx Pharmaceuticals, Inc.
|
1,107,271 | $15,391,066 | |
| 7 | AQST |
Aquestive Therapeutics, Inc.
|
2,900,570 | $12,037,365 | |
| 8 | PRGO |
PERRIGO Co plc
This page
|
804,856 | $8,644,153 |
All Filings in PRGO
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $8,644,153 | 804,856 | Shares | Sole | 2026-05-15 | |
| 2024-06-30 | $14,740,037 | 573,989 | Shares | Sole | 2024-08-14 | |
| 2023-12-31 | $1,877,605 | 58,347 | Shares | Other | 2024-02-14 | |
| 2023-09-30 | $20,191,057 | 631,958 | Shares | Other | 2023-11-14 | |
| 2023-06-30 | $37,897,841 | 1,116,284 | Shares | Other | 2023-08-14 | |
| 2022-12-31 | $33,133,297 | 971,936 | Shares | Other | 2023-02-14 | |
| 2022-09-30 | $17,239,898 | 483,452 | Shares | Sole | 2022-11-15 | |
| 2022-06-30 | $28,443,667 | 701,101 | Shares | Other | 2022-08-15 | |
| 2022-06-30 | $10,953,900 | 270,000 | Call | Sole | 2022-08-15 | |
| 2022-03-31 | $26,552,478 | 690,931 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $32,001,863 | 822,670 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $8,961,367 | 189,338 | Shares | Sole | 2021-12-01 | |
| 2021-06-30 | $797,331 | 17,390 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $7,026,118 | 173,613 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $1,126,273 | 25,185 | Shares | Sole | 2021-02-16 | |
| 2020-06-30 | $11,813,575 | 213,743 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $19,256,293 | 400,422 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||